Immunome IMNM Stock
5.93 USD
{{ price }}
-4.967948%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
515.62M USD
LOW - HIGH [24H]
5.75
-
6.2 USD
VOLUME [24H]
1.11M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-5 USD
Immunome Price Chart
Immunome IMNM Financial and Trading Overview
| Immunome stock price | 5.93 USD |
| Previous Close | 5.28 USD |
| Open | 5.31 USD |
| Bid | 0 USD x 3000 |
| Ask | 0 USD x 800 |
| Day's Range | 5.25 - 5.49 USD |
| 52 Week Range | 2.2 - 7.42 USD |
| Volume | 9.23K USD |
| Avg. Volume | 29.2K USD |
| Market Cap | 65.23M USD |
| Beta (5Y Monthly) | 1.731779 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8 USD |
IMNM Valuation Measures
| Enterprise Value | 20.31M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.282353 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 27.592258 |
| Price/Book (mrq) | 4.6965704 |
| Enterprise Value/Revenue | 8.59 |
| Enterprise Value/EBITDA | -0.693 |
Trading Information
Immunome Stock Price History
| Beta (5Y Monthly) | 1.731779 |
| 52-Week Change | 110.23% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.42 USD |
| 52 Week Low | 2.2 USD |
| 50-Day Moving Average | 5.38 USD |
| 200-Day Moving Average | 4.75 USD |
IMNM Share Statistics
| Avg. Volume (3 month) | 29.2K USD |
| Avg. Daily Volume (10-Days) | 21.68K USD |
| Shares Outstanding | 12.22M |
| Float | 10.2M |
| Short Ratio | 3.81 |
| % Held by Insiders | 18.94% |
| % Held by Institutions | 17.32% |
| Shares Short | 147.46K |
| Short % of Float | 1.37% |
| Short % of Shares Outstanding | 1.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1257.10% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -38.75% |
| Return on Equity (ttm) | -114.091% |
Income Statement
| Revenue (ttm) | 2.36M USD |
| Revenue Per Share (ttm) | 0.2 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -29313000 USD |
| Net Income Avi to Common (ttm) | -30135000 USD |
| Diluted EPS (ttm) | -2.52 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 44.42M USD |
| Total Cash Per Share (mrq) | 3.64 USD |
| Total Debt (mrq) | 236K USD |
| Total Debt/Equity (mrq) | 1.7 USD |
| Current Ratio (mrq) | 1.874 |
| Book Value Per Share (mrq) | 1.137 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.86M USD |
| Levered Free Cash Flow (ttm) | 3.21M USD |
Profile of Immunome
| Country | United States |
| State | PA |
| City | Exton |
| Address | 665 Stockton Drive |
| ZIP | 19341 |
| Phone | 610 321 3700 |
| Website | https://immunome.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 37 |
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01 that targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Q&A For Immunome Stock
What is a current IMNM stock price?
Immunome IMNM stock price today per share is 5.93 USD.
How to purchase Immunome stock?
You can buy IMNM shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Immunome?
The stock symbol or ticker of Immunome is IMNM.
Which industry does the Immunome company belong to?
The Immunome industry is Biotechnology.
How many shares does Immunome have in circulation?
The max supply of Immunome shares is 86.95M.
What is Immunome Price to Earnings Ratio (PE Ratio)?
Immunome PE Ratio is now.
What was Immunome earnings per share over the trailing 12 months (TTM)?
Immunome EPS is -5 USD over the trailing 12 months.
Which sector does the Immunome company belong to?
The Immunome sector is Healthcare.
Immunome IMNM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}